| meprobamate, menthol, menadiol sodium phosphate | |
| mepyramine, mercaptopurine, meropenem |
| Systematic (IUPAC) name | |
|---|---|
| (RS)-3-(3-ethyl-1-methylazepan-3-yl)phenol | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | POM (UK) |
| Dependence liability | Low |
| Routes | Oral, IM, IV |
| Pharmacokinetic data | |
| Metabolism | The peak analgesic effect is seen within 30–60 minutes and lasts about 3–4 hours. |
| Half-life | Half-Life (1.4–4 hours). |
| Excretion | The drug is rapidly metabolised to the glucuronide, and mostly excreted in the urine. |
| Identifiers | |
| CAS number | 54340-58-8 |
| ATC code | N02AX05 |
| PubChem | CID 41049 |
| ChemSpider | 37469 |
| UNII | 18Y7S5JKZD |
| KEGG | D08182 |
| ChEMBL | CHEMBL314437 |
| Chemical data | |
| Formula | C15H23NO |
| Mol. mass | 233.34922 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
Meptazinol (trade name Meptid) is an opioid analgesic for use with moderate to severe pain, most commonly used to treat pain in obstetrics (childbirth). A partial µ-opioid receptor agonist, its mixed agonist/antagonist activity affords it a lower risk of dependence and abuse than full µ agonists like morphine. Meptazinol exhibits not only a short onset of action, but also a shorter duration of action relative to other opioids such as morphine, pentazocine, or buprenorphine.[1]
| This analgesic-related article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)